Article detail · 2022
2‐Amino thiazole derivatives as inhibitors of some metabolic enzymes: An in vitro and in silico study
- Year
- 2022
- DOI
- 10.1002/bab.2388
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Biotechnology and Applied Biochemistry
- Catalog match (ISSN) Biotechnology and Applied Biochemistry
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
English (OpenAlex)
Abstract The thiazole derivatives are desirable compounds in the evaluation of their biological activities such as antiprotozoal antibacterial, antifungal, antituberculosis. Considering the medical application potential of 2‐amino thiazole compounds, we aimed to determine the effects of 2‐amino thiazole derivatives on the activities of carbonic anhydrase I–II isoenzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the chemicals we used in our study, 2‐amino‐4‐(4‐chlorophenyl)thiazole compound exhibited the best inhibition against hCA I with Ki of 0.008 ± 0.001 μM. The 2‐amino‐4‐(4‐bromophenyl)thiazole compound exhibited the best inhibition against hCA II, AChE, and BChE with Ki of 0.124 ± 0.017, 0.129 ± 0.030, and 0.083 ± 0.041 μM, respectively. Molecular docking analysis showed that compound 2‐amino‐4‐(5,6,7,8‐tetrahydro‐2‐naphthyl)thiazole had the highest inhibitory potency against hCA I, hCA II, AChE, BChE with the estimated binding energy of −6.75, −7.61, −7.86, −7.96 kcal/mol, respectively.
Topics
- Enzyme function and inhibition
- Cholinesterase and Neurodegenerative Diseases
- Phenothiazines and Benzothiazines Synthesis and Activities
Primary topic Enzyme function and inhibition